Tristel: Waiting for the US to deliver

Last year was a rough one for Tristel but it still remains a very good business. The potential opportunity in the US market looks priced in.

Photo by JAFAR AHMED on Unsplash

I see a lot of reasons for investors to like a business such as Tristel.

First and foremost, its business is very easy to understand. Most of its money is made selling disinfectants for medical devices used in hospitals under the Tristel brand. It also sells surface disinfectants under the Cache brand and has a very small business selling animal disinfectant products.

To keep reading sign up for an annual or monthly subscription here. If you're already a subscriber log in here.

Enjoying this article?   

Join our list for more quality insight and analysis. No spam, unsubscribe any time.

%d bloggers like this: